These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 8524723)

  • 21. Complete diagnostic evaluation in colorectal cancer screening: research design and baseline findings.
    Myers RE; Turner B; Weinberg D; Hauck WW; Hyslop T; Brigham T; Rothermel T; Grana J; Schlackman N
    Prev Med; 2001 Oct; 33(4):249-60. PubMed ID: 11570828
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Are patients with hyperlipidemia being treated? Investigation of cholesterol treatment practices in an HMO primary care setting.
    Lai LL; Poblet M; Bello C
    South Med J; 2000 Mar; 93(3):283-6. PubMed ID: 10728515
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Reducing low-density lipoprotein cholesterol levels in an ambulatory care system. Results of a multidisciplinary collaborative practice lipid clinic compared with traditional physician-based care.
    Shaffer J; Wexler LF
    Arch Intern Med; 1995 Nov; 155(21):2330-5. PubMed ID: 7487258
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Self-reported physician practices for children with asthma: are national guidelines followed?
    Finkelstein JA; Lozano P; Shulruff R; Inui TS; Soumerai SB; Ng M; Weiss KB
    Pediatrics; 2000 Oct; 106(4 Suppl):886-96. PubMed ID: 11044140
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Community screening for hypercholesterolemia.
    Bell MM; Joseph S
    J Fam Pract; 1990 Oct; 31(4):365-8. PubMed ID: 2212966
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Statin therapy in Canadian patients with hypercholesterolemia: the Canadian Lipid Study -- Observational (CALIPSO).
    Bourgault C; Davignon J; Fodor G; Gagné C; Gaudet D; Genest J; Lavoie MA; Leiter L; McPherson R; Sénécal M; Marentette M; Sebaldt RJ
    Can J Cardiol; 2005 Nov; 21(13):1187-93. PubMed ID: 16308595
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Implications of changing national cholesterol education program goals for the treatment and control of hypercholesterolemia.
    Persell SD; Lloyd-Jones DM; Baker DW
    J Gen Intern Med; 2006 Feb; 21(2):171-6. PubMed ID: 16390501
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Patients' anxiety and expectations: how they influence family physicians' decisions to order cancer screening tests.
    Haggerty J; Tudiver F; Brown JB; Herbert C; Ciampi A; Guibert R
    Can Fam Physician; 2005 Dec; 51(12):1658-9. PubMed ID: 16926946
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Results of a cross-sectional survey about lipid-management practices among cardiologists in Pakistan: assessment of adherence to published treatment guidelines.
    Gowani SA; Shoukat S; Taqui AM; Bhulani N; Khalid S; Sheikh A; Halim MS; Samreen S; Jafary FH
    Clin Ther; 2009 Jul; 31(7):1604-14. PubMed ID: 19695410
    [TBL] [Abstract][Full Text] [Related]  

  • 30. New therapeutic options in the National Cholesterol Education Program Adult Treatment Panel III.
    Talbert RL
    Am J Manag Care; 2002 Sep; 8(12 Suppl):S301-7. PubMed ID: 12240701
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Influence of physician and patient characteristics on adherence to breast cancer screening recommendations.
    Abdel-Malek N; Chiarelli AM; Sloan M; Stewart DE; Mai V; Howlett RI
    Eur J Cancer Prev; 2008 Feb; 17(1):48-53. PubMed ID: 18090910
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Physician follow-up of a community cholesterol-screening project.
    Kass D; Hickner J
    Fam Pract Res J; 1991 Jun; 11(2):139-48. PubMed ID: 2058407
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cholesterol-lowering intervention program. Effect of the step I diet in community office practices.
    Caggiula AW; Watson JE; Kuller LH; Olson MB; Milas NC; Berry M; Germanowski J
    Arch Intern Med; 1996 Jun; 156(11):1205-13. PubMed ID: 8639015
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Screening for hypercholesterolemia in a family practice residency.
    Keller KG; Ogle KS
    Fam Pract Res J; 1989; 8(2):85-91. PubMed ID: 2741729
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Systematic cholesterol screening during acute care visits.
    Hahn DL
    J Am Board Fam Pract; 1993; 6(6):529-36. PubMed ID: 8285091
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The effect of physician office visits on CHD risk factor modification as part of a worksite cholesterol screening program.
    Wang JS; Carson EC; Lapane KL; Eaton CB; Gans KM; Lasater TM
    Prev Med; 1999 Mar; 28(3):221-8. PubMed ID: 10072739
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cholesterol screening in general practice.
    Jacobs L
    J R Coll Gen Pract; 1988 Jul; 38(312):321. PubMed ID: 3255830
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Results of the Massachusetts Model Systems for Blood Cholesterol Screening Project.
    Havas S; Koumjian L; Reisman J; Hso L; Wozenski S
    JAMA; 1991 Jul; 266(3):375-81. PubMed ID: 2056647
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Japanese guidelines-based management of lipid levels in a hypercholesterolemia education class.
    Kotani K; Katase H; Saiga K; Sakane N
    Arch Med Res; 2006 Jan; 37(1):175-7. PubMed ID: 16314206
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Evaluation of implementation of a cholesterol management program in physicians' offices.
    Glanz K; Brekke M; Harper D; Bache-Wiig M; Hunninghake DB
    Health Educ Res; 1992 Jun; 7(2):151-63. PubMed ID: 10148737
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.